M-2698 Completed Phase 1 Trials for Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01971515
First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies